Navigation Links
MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting
Date:5/4/2013

GAITHERSBURG, Md., May 4, 2013 /PRNewswire/ -- MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E. Washington Convention Center in Washington DC, May 4-7, 2013.  These abstracts advance the body of existing data and knowledge around influenza and respiratory syncytial virus (RSV) prevention, highlighting MedImmune's continued commitment to patient health.

MedImmune posters to be presented at PAS regarding influenza include:

  • Efficacy of Live Attenuated Influenza Vaccine Against Moderate to Severe Versus Mild Influenza Illness in Children. Ambrose CS, Wu X, Belshe RB. Platform Presentation Session: May 4, 2013, 9:45 AM, Session: Section 115- Infectious Diseases, Vaccines & Infections 

  • Serum HAI Antibody Response to LAIV in 2 to 49 Year Olds.Coelingh K, Wu X, Mallory R, Ambrose CS. Poster Session: May 4, 2013, 1:00 PM – 4:00 PM; Exhibit Hall D/E; Board: 493

MedImmune posters to be presented at PAS regarding RSV include:

  • Burden of and Risk Factors for Medically Attended RSV Illness in 32−35 w/GA Infants Not Receiving RSV Prophylaxis. Groothuis J, Wu X, Makari D, Ambrose CS.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.4. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 4

  • Risk for Medically Attended RSV Illness in 32−34 Weeks vs. 35 Weeks Gestational Age Preterm Infants Not Receiving Palivizumab.  Groothuis J, Wu X, Makari D, Ambrose CS.  Publication Number 1500.3.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 3 

  • Respiratory Syncytial Virus Surveillance, 2007–2012: Results from RSVAlert®, a U.S. National Hospital-Based Surveillance Program. Boron M, Kumar V, McGuiness CB, Saunders B, Rabon-Stith K .  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.7, Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 7

  • Impact of Partial Prophylaxis with Palivizumab on RSV Hospitalizations among Commercially-Insured High-Risk Preterm Infants. Ryan K, Stewart D, Frogel M, Becker L, Pinsky B. Poster Session : May 5, 2013, 4:15 pm− 7:30 pm. Publication Number: 2915.209. Session: 2915 − Infectious Diseases, Exhibit Hall D/E, Board: 209

  • Pharmacokinetic (PK) Profile of Palivizumab (Pali) in Premature Infants. La Via WV, Makari D, Yu X, Robbie GJ. Poster Session: May 7, 2013, 10:00 am− 2:00 pm. Publication Number: 4514.228.  Session: 4514 − Neonatal Infectious Diseases / Immunology, Exhibit Hall D/E, Board: 228

Additional information about the 2013 PAS conference can be found at
http://www.pas-meeting.org/2013DC/default.asp 

About MedImmune 
MedImmune is the worldwide biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines.  MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines.  MedImmune has approximately 2,500 employees globally, with its headquarters located in Gaithersburg, Md., one of AstraZeneca's three global R&D centers.  For more information, please visit www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
2. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
3. Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
4. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
5. Zimmer Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
6. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
7. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
8. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
9. XBiotech to Present at UBS Global Healthcare Conference
10. Leonhardt Ventures to Present Technology Showcase @ Heart Rhythm 2013
11. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):